Cargando…

MGMT Promoter Methylation and Parathyroid Carcinoma

CONTEXT: Parathyroid carcinoma (PC) is extremely rare. Prognosis is poor, with no known evidence-based systemic therapies. We previously reported complete remission in a patient with metastasized parathyroid carcinoma and high tumor MGMT promoter methylation status who was treated with temozolomide....

Descripción completa

Detalles Bibliográficos
Autores principales:	Storvall, Sara, Ryhänen, Eeva, Heiskanen, Ilkka, Vesterinen, Tiina, Bensch, Frank V, Schildt, Jukka, Kytölä, Soili, Karhu, Auli, Arola, Johanna, Schalin-Jäntti, Camilla
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Endocrine Society 2019
Materias:	Clinical Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6821197/ https://www.ncbi.nlm.nih.gov/pubmed/31687638 http://dx.doi.org/10.1210/js.2019-00175

Ejemplares similares

Recurrent Metastasized Parathyroid Carcinoma—Long‐Term Remission After Combined Treatments With Surgery, Radiotherapy, Cinacalcet, Zoledronic Acid, and Temozolomide
por: Storvall, Sara, et al.
Publicado: (2018)

Novel PRUNE2 Germline Mutations in Aggressive and Benign Parathyroid Neoplasms
por: Storvall, Sara, et al.
Publicado: (2023)

Somatostatin receptor expression in parathyroid neoplasms
por: Storvall, Sara, et al.
Publicado: (2019)

(99m)Technetium Sestamibi-(123)Iodine Scintigraphy Is More Accurate Than (99m)Technetium Sestamibi Alone before Surgery for Primary Hyperparathyroidism
por: Ryhänen, Eeva M., et al.
Publicado: (2015)

CDC73 Intragenic Deletion in Familial Primary Hyperparathyroidism Associated With Parathyroid Carcinoma
por: Korpi-Hyövälti, Eeva, et al.
Publicado: (2014)

Health-related quality of life is impaired in primary hyperparathyroidism and significantly improves after surgery: a prospective study using the 15D instrument
por: Ryhänen, Eeva M, et al.
Publicado: (2015)

Prediction of the aggressiveness of non-functional pancreatic neuroendocrine tumors based on the dual-tracer PET/CT
por: Majala, Susanna, et al.
Publicado: (2019)

Correlation of Somatostatin Receptor 1–5 Expression, [(68)Ga]Ga-DOTANOC, [(18)F]F-FDG PET/CT and Clinical Outcome in a Prospective Cohort of Pancreatic Neuroendocrine Neoplasms
por: Majala, Susanna, et al.
Publicado: (2021)

Prolonged Hypophosphatemia and Intensive Care After Curative Surgery of Tumor Induced Osteomalacia: A Case Report
por: Ryhänen, Eeva M., et al.
Publicado: (2021)

IDH1 Expression via the R132H Mutation–Specific Antibody in Adrenocortical Neoplasias—Prognostic Impact in Carcinomas
por: Pennanen, Mirkka, et al.
Publicado: (2020)

Adrenocortical carcinoma: presentation and outcome of a contemporary patient series
por: Kostiainen, Iiro, et al.
Publicado: (2019)

Screening for germline KCNQ1 and KCNE2 mutations in a set of somatotropinoma patients
por: Iivonen, Anna-Pauliina, et al.
Publicado: (2018)

Mutation Analysis of Inhibitory Guanine Nucleotide Binding Protein Alpha (GNAI) Loci in Young and Familial Pituitary Adenomas
por: Demir, Hande, et al.
Publicado: (2014)

Adrenal androgens versus cortisol for primary aldosteronism subtype determination in adrenal venous sampling
por: Viukari, Marianna, et al.
Publicado: (2022)

Use Of Temozolomide In Parathyroid Carcinoma With Negative Mgmt Promoter Methylation
por: Reddy, Niyoti, et al.
Publicado: (2021)

Cushing's syndrome, pheochromocytoma, or both?
por: Kullamaa, Liisa, et al.
Publicado: (2023)

Orthopedia homeobox protein (OTP) in the diagnostic and prognostic workup of pulmonary carcinoid tumors
por: Vesterinen, Tiina, et al.
Publicado: (2022)

Association between MGMT Enhancer Methylation and MGMT Promoter Methylation, MGMT Protein Expression, and Overall Survival in Glioblastoma
por: Zappe, Katja, et al.
Publicado: (2023)

Thymic neuroendocrine tumors in patients with multiple endocrine neoplasia type 1
por: Yliaska, Iina, et al.
Publicado: (2022)

Unmet therapeutic, educational and scientific needs in parathyroid disorders: Consensus Statement from the first European Society of Endocrinology Workshop (PARAT)
por: Bollerslev, Jens, et al.
Publicado: (2019)

Clonal dynamics using droplet digital polymerase chain reaction in peripheral blood predicts treatment responses in myelodysplastic syndrome
por: Illman, Johanna, et al.
Publicado: (2022)

European expert consensus on practical management of specific aspects of parathyroid disorders in adults and in pregnancy: recommendations of the ESE Educational Program of Parathyroid Disorders (PARAT 2021)
por: Bollerslev, Jens, et al.
Publicado: (2021)

Comparison of Serum and Urinary 5-Hydroxyindoleacetic Acid as Biomarker for Neuroendocrine Neoplasms
por: Becker, Anna, et al.
Publicado: (2021)

WNT2 activation through proximal germline deletion predisposes to small intestinal neuroendocrine tumors and intestinal adenocarcinomas
por: Aavikko, Mervi, et al.
Publicado: (2021)

Absence of the MGMT protein as well as methylation of the MGMT promoter predict the sensitivity for temozolomide
por: van Nifterik, K A, et al.
Publicado: (2010)

Comparison of Five Parathyroid Scintigraphic Protocols
por: Tunninen, Virpi, et al.
Publicado: (2013)

Long-term morbidity and mortality in patients diagnosed with an insulinoma
por: Peltola, Elina, et al.
Publicado: (2021)

HSP90 expression is associated with outcome in pulmonary carcinoid tumor patients
por: Niinimäki, Jenni, et al.
Publicado: (2023)

Comprehensive Analysis of MGMT Promoter Methylation: Correlation with MGMT Expression and Clinical Response in GBM
por: Shah, Nameeta, et al.
Publicado: (2011)

Prognostic impact of MGMT promoter methylation and MGMT and CD133 expression in colorectal adenocarcinoma
por: Oliver, Jaime Antonio, et al.
Publicado: (2014)

A 5-Year Prospective Follow-Up Study of Lipid-Rich Adrenal Incidentalomas: No Tumor Growth or Development of Hormonal Hypersecretion
por: Schalin-Jäntti, Camilla, et al.
Publicado: (2015)

N-Glycomic Profiling of Microsatellite Unstable Colorectal Cancer
por: Ukkola, Iiris, et al.
Publicado: (2023)

MGMT promoter methylation in Peruvian patients with glioblastoma
por: Belmar-Lopez, Carolina, et al.
Publicado: (2018)

Evaluation of MGMT Gene Methylation in Neuroendocrine Neoplasms
por: Della Monica, Rosa, et al.
Publicado: (2022)

Fast routine assessment of MGMT promoter methylation
por: Hench, Ivana Bratic, et al.
Publicado: (2020)

An evaluation of MGMT promoter methylation within the methylation subclasses of glioblastoma
por: Alnahhas, Iyad, et al.
Publicado: (2020)

The MGMT promoter single-nucleotide polymorphism rs1625649 had prognostic impact on patients with MGMT methylated glioblastoma
por: Hsu, Chih-Yi, et al.
Publicado: (2017)

MGMT Methylation Status: The Advent of Stratified Therapy in Glioblastoma?
por: Hau, Peter, et al.
Publicado: (2007)

The Significance of MGMT Promoter Methylation Status in Diffuse Glioma
por: Jovanović, Nikola, et al.
Publicado: (2022)

MGMT Promoter Methylation: Prognostication beyond Treatment Response
por: Ashkan, Keyoumars, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_enrpr6pif7cp54m7con7vcjjn3